Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [ ¹⁸ F]SiTATE - first clinical experiences.

Autor: Kunte SC; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Wenter V; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Toms J; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Lindner S; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Unterrainer M; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; DIE RADIOLOGIE, Munich, Germany., Eilsberger F; Department of Nuclear Medicine, School of Medicine, Philipps University Marburg, Marburg, Germany., Jurkschat K; Fakultät für Chemie und Chemische Biologie, Technische Universität Dortmund, Dortmund, Germany., Wängler C; Biomedical Chemistry, Clinic of Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.; Research Campus M²OLIE, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany., Wängler B; Research Campus M²OLIE, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.; Medical Faculty Mannheim of Heidelberg University, Molecular Imaging and Radiochemistry, Clinic of Radiology and Nuclear Medicine, Mannheim, Germany., Schirrmacher R; Department of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, AB, Canada., Tiling MW; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Sheikh GT; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany., Mehrens D; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany., Brendel M; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; DZNE - German Center for Neurodegenerative Diseases, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), University of Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a Partnership Between DKFZ and Ludwig-Maximilians-Universität München (LMU), Munich, Germany., Rübenthaler J; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany., Auernhammer CJ; Department of Internal Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Spitzweg C; Department of Internal Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany., Unterrainer LM; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.; Bayerisches Zentrum für Krebsforschung (BZKF), Partner Site Munich, Munich, Germany., Holzgreve A; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Adrien.Holzgreve@med.lmu.de.; Ahmanson Translational Theranostics Division, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Adrien.Holzgreve@med.lmu.de.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Oct 15. Date of Electronic Publication: 2024 Oct 15.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Lenticulostriatal Ischemia Shows Relevant SSTR Expression on PET/CT Imaging Using the Novel SSTR-Targeting Peptide 18 F-SiTATE.

Autor: Kunte SC; From the Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Unterrainer LM, Kunz WG; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Winkelmann M; Department of Radiology, University Hospital, LMU Munich, Munich, Germany., Lindner S; From the Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Jurkschat K; Fakultät für Chemie und Chemische Biologie, Technische Universität Dortmund, Dortmund, Germany., Wängler C; Biomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany., Wängler B; Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany., Schirrmacher R; Department of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, Alberta, Canada., Bartenstein P; From the Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Schichor C; Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany., Albert NL; From the Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany., Unterrainer M

Publikováno v: Clinical nuclear medicine [Clin Nucl Med] 2024 Dec 01; Vol. 49 (12), pp. e689-e690. Date of Electronic Publication: 2024 Oct 02.

Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [18F]SiTATE PET

Autor: Carmen Wängler, Leonie Beyer, Peter Bartenstein, Björn Wängler, Ralf Schirrmacher, Simon Lindner

Publikováno v: EJNMMI Radiopharmacy and Chemistry, Vol 7, Iss 1, Pp 1-4 (2022)

Externí odkaz: https://doaj.org/article/1f412ef2ab4744d3aca800146c8151d2